NeuroSense Therapeutics Ltd. Other Noncash Income (Expense)
NeuroSense Therapeutics Ltd. (NRSN) reported Other Noncash Income (Expense) of $46.00 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-31.
Financial Statements › Cash Flow › Operating Activities
us-gaap:OtherNoncashIncomeExpense · last filed 2026-03-31
| Period end | Other Noncash Income (Expense) 6 month | Other Noncash Income (Expense) 12 month |
|---|---|---|
| 2025-12-31 | $46.00K 20-F · filed 2026-03-31 | |
| 2024-12-31 | -$323.00K 20-F · filed 2026-03-31 | |
| 2023-12-31 | -$473.00K 20-F · filed 2026-03-31 | |
| 2023-06-30 | -$487.00K 6-K · filed 2024-09-30 | |
| 2022-12-31 | -$41.00K 6-K · filed 2024-06-17 | |
| 2021-12-31 | $20.00K 6-K · filed 2024-06-17 |